• Taysha Gene Therapies (TSHA) Could Be 49% Below Fair Value After Russell Index Drop simplywall.st Fri, 10 Jul 2026 13:02:15 GMT
• Will Russell Index Removals and New Rett Data Change Taysha Gene Therapies' (TSHA) Narrative? simplywall.st Wed, 08 Jul 2026 07:38:36 GMT
• Needham Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $12 富途牛牛 Fri, 03 Jul 2026 18:17:44 GMT
• neurogene: 'hold' embolden study underway and 2nd half 2027 topline data Seeking Alpha Thu, 02 Jul 2026 18:33:00 GMT
• Citizens reiterates Taysha Gene Therapies stock rating on therapy progress Investing.com Thu, 02 Jul 2026 07:00:00 GMT
• Taysha’s TSHA-102 Rett Data Links Clinical Promise To Future Revenue Sahm Wed, 01 Jul 2026 18:24:36 GMT
• Baird Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Raises Target Price to $15 富途牛牛 Wed, 01 Jul 2026 13:46:07 GMT
• A Quick Look at Today's Ratings for Taysha Gene Therapies(TSHA.US), With a Forecast Between $12 to $15 Moomoo Wed, 01 Jul 2026 13:03:46 GMT
• enterprise value to ebitda forward of taysha gene therapies, inc. – nasdaq:tsha TradingView Wed, 01 Jul 2026 05:50:02 GMT
• tsha maintained by needham -- price target holds at $12.00 GuruFocus Tue, 30 Jun 2026 21:32:38 GMT
• enterprise value to ebitda forward of taysha gene therapies, inc. – boats:tsha TradingView Tue, 30 Jun 2026 20:29:18 GMT
• Price to sales forward of Taysha Gene Therapies, Inc. – NASDAQ:TSHA TradingView Tue, 30 Jun 2026 17:06:23 GMT
• Baird Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Raises Target Price to $15 Moomoo Tue, 30 Jun 2026 11:31:00 GMT
• Taysha: 'Buy' On Interim Analysis Of TSHA-102 First Half 2027 And Broad Label Potential Seeking Alpha Tue, 30 Jun 2026 07:00:00 GMT
• Price to book forward of Taysha Gene Therapies, Inc. – NASDAQ:TSHA TradingView Tue, 30 Jun 2026 05:28:00 GMT
• Enterprise value to EBIT forward of Taysha Gene Therapies, Inc. – BOATS:TSHA TradingView Tue, 30 Jun 2026 01:02:53 GMT
• price to earnings forward of taysha gene therapies, inc. – boats:tsha TradingView Tue, 30 Jun 2026 00:59:40 GMT
• Taysha Gene Therapies, Inc. Stock 12‑Month Price Target Raised to $13, Implies 105% Upside TradingView Mon, 29 Jun 2026 22:20:05 GMT
• Rett Data and $200 Million Raise Might Change The Case For Investing In Taysha (TSHA) simplywall.st Mon, 29 Jun 2026 12:18:01 GMT
• Taysha Gene Therapies, Inc.(NasdaqGS: TSHA) dropped from Russell Microcap Index marketscreener.com Mon, 29 Jun 2026 09:45:35 GMT
• Taysha Gene Therapies, Inc.(NasdaqGS:TSHA) dropped from Russell Microcap Growth Benchmark Index marketscreener.com Mon, 29 Jun 2026 07:00:00 GMT
• taysha gene therapies launches $200m public offering; shares down MSN Sat, 27 Jun 2026 02:06:09 GMT
• taysha gene therapies launches $200m public offering; shares down MSN Fri, 26 Jun 2026 11:09:02 GMT
• taysha gene therapies inc (tsha) technical analysis: support, resistance, indicators & moving averages TradingKey Fri, 26 Jun 2026 08:35:37 GMT
• taysha gene therapies announces major equity financing deal The Globe and Mail Fri, 26 Jun 2026 07:00:00 GMT
• taysha gene therapies shares tumble following pricing shares at $6.00 to raise $200m MSN Fri, 26 Jun 2026 03:22:06 GMT
• taysha gene therapies stock tumbles on public offering pricing Investing.com Fri, 26 Jun 2026 00:37:29 GMT
• form 424b5 taysha gene therapies inc for: 25 june by investing.com Investing.com Nigeria Thu, 25 Jun 2026 23:39:38 GMT
• Taysha Gene Therapies Announces Multiple Presentations GlobeNewswire Thu, 25 Jun 2026 20:01:00 GMT
• Taysha Gene Therapies Down Over 11%, on Pace for Largest Percent Decrease Since May 2025 -- Data Talk Moomoo Thu, 25 Jun 2026 19:06:00 GMT
• Taysha Gene Therapies, Inc. Actuals & Estimates (NASDAQ:TSHA) TradingView Thu, 25 Jun 2026 16:39:44 GMT
• taysha gene therapies (tsha) shares fall 9.2% following $200m pu GuruFocus Thu, 25 Jun 2026 07:53:27 GMT
• Taysha Gene Therapies (NASDAQ: TSHA) prices $200M equity raise with warrants Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies Prices $200 Million Public Offering of Common Stock and Pre-Funded Warrants Quiver Quantitative Thu, 25 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies Prices Equity Offering for ~$187.4 Million Net, Grants 5 Million Share Option TradingView Thu, 25 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies to present Rett syndrome data at conference Investing.com Thu, 25 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies stock tumbles on public offering pricing Investing.com Thu, 25 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies (TSHA) priced 32.5M-share offering; $187M net proceeds Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• taysha lines up tsha-102 data on rett syndrome at june 29 meeting Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• taysha gene therapies prices $200m public offering of common stock and pre-funded warrants Pluang Thu, 25 Jun 2026 03:09:01 GMT
• Taysha Gene Therapies prices $200M stock offering at $6 per share Investing.com Canada Thu, 25 Jun 2026 02:48:33 GMT
• taysha gene therapies: offering expected to close on or abour june 26 >tsha Moomoo Thu, 25 Jun 2026 02:35:00 GMT
• taysha gene therapies announces pricing of public offering of common stock and pre-funded warrants GlobeNewswire Thu, 25 Jun 2026 02:33:00 GMT
• form 424b5 taysha gene therapies inc for: 24 june by investing.com Investing.com Nigeria Wed, 24 Jun 2026 22:05:32 GMT
• All Rett patients in trial achieve motor milestones with gene therapy Rett Syndrome News Wed, 24 Jun 2026 21:17:38 GMT
• taysha gene therapies prices $200m public offering of common stock scanx.trade Wed, 24 Jun 2026 20:59:44 GMT
• Taysha Gene Therapies launches $200M public offering; shares down MSN Wed, 24 Jun 2026 20:50:12 GMT
• taysha gene therapies begins $200m offering with pre-funded warrants Stock Titan Wed, 24 Jun 2026 20:01:00 GMT
• jefferies sticks to their buy rating for taysha gene therapies (tsha) The Globe and Mail Wed, 24 Jun 2026 13:37:16 GMT
• Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire Wed, 24 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire Wed, 24 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies launches $200 million stock offering Investing.com Wed, 24 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies: Offering Expected to Close on or Abour June 26 >TSHA Moomoo Wed, 24 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies prices $200M stock offering at $6 per share Investing.com Wed, 24 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies Inc Files For Mixed Shelf Offering Of Up To $200 Million - SEC Filing TradingView Wed, 24 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies stock tumbles on $200M stock offering Investing.com Wed, 24 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies (TSHA) files $200M common stock and pre-funded warrants offering Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• tsha maintains by citizens -- price target raised to $11.00 GuruFocus Wed, 24 Jun 2026 05:26:15 GMT
• citizens jmp maintains taysha gene therapies(tsha.us) with buy rating, raises target price to $11 Moomoo Wed, 24 Jun 2026 00:23:32 GMT
• needham maintains taysha gene therapies(tsha.us) with buy rating, maintains target price $12 Moomoo Tue, 23 Jun 2026 16:24:53 GMT
• tsha maintained by bmo capital -- price target raised to $14.00 GuruFocus Tue, 23 Jun 2026 16:07:03 GMT
• taysha gene therapies price target raised to $14 from $10 at bmo capital TipRanks Tue, 23 Jun 2026 16:04:24 GMT
• tsha maintained by b of a securities -- price target raised to $10.00 GuruFocus Tue, 23 Jun 2026 14:42:18 GMT
• bmo capital maintains taysha gene therapies(tsha.us) with buy rating, raises target price to $14 Moomoo Tue, 23 Jun 2026 13:31:01 GMT
• tsha maintains by citizens -- price target raised to $11.00 GuruFocus Tue, 23 Jun 2026 13:27:11 GMT
• citizens jmp maintains taysha gene therapies(tsha.us) with buy rating, raises target price to $11 Moomoo Tue, 23 Jun 2026 10:31:00 GMT
• taysha gene therapies (tsha) completes dosing in pivotal trial GuruFocus Tue, 23 Jun 2026 09:49:49 GMT
• Citizens raises Taysha Gene Therapies price target on trial data By Investing.com Investing.com Canada Tue, 23 Jun 2026 09:30:47 GMT
• taysha gene therapies announces completion of dosing in reveal pivotal trial and reports longer-term clinical data from part a of ... Investing News Network Tue, 23 Jun 2026 08:47:56 GMT
• Taysha Gene Therapies, Inc. (TSHA) Discusses Longer-Term Clinical Data and Program Update for TSHA-102 in Rett Syndrome - Slidesho... Seeking Alpha Tue, 23 Jun 2026 07:00:00 GMT
• BMO raises Taysha Gene Therapies stock price target on trial data Investing.com Tue, 23 Jun 2026 07:00:00 GMT
• BofA Securities Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Raises Target Price to $10 Moomoo Tue, 23 Jun 2026 07:00:00 GMT
• taysha gene therapies stock rises on rett syndrome trial data Investing.com Tue, 23 Jun 2026 00:45:05 GMT
• taysha gene therapies, inc. stock 12‑month price target raised to $12.31, implies 92% upside TradingView Mon, 22 Jun 2026 22:20:04 GMT
• taysha gene therapies (tsha) completes dosing in pivotal trial GuruFocus Mon, 22 Jun 2026 13:05:37 GMT
• form 8k taysha gene therapies inc for: 22 june by investing.com Investing.com Nigeria Mon, 22 Jun 2026 13:01:08 GMT
• Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of ... Yahoo Finance Mon, 22 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies stock price target raised to $10 by BofA on trial data Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• Taysha Advances Rett Syndrome Programme as Pivotal Trial Enrollment Completes (TSHA) Yahoo Finance Mon, 22 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies (TSHA) Stock Could Be 47.5% Undervalued After Rett Trial Progress simplywall.st Mon, 22 Jun 2026 07:00:00 GMT
• TSHA Gene Therapies (Nasdaq: TSHA) shows 100% Rett response, eyes TSHA-102 BLA Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies stock rises on Rett syndrome trial data Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• Taysha completes dosing in Rett syndrome pivotal trial Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• needham maintains taysha gene therapies(tsha.us) with buy rating, maintains target price $12 Moomoo Mon, 22 Jun 2026 07:00:00 GMT
• why taysha gene therapies (tsha) is up 12.4% after institutions tighten their grip on shares simplywall.st Sat, 20 Jun 2026 07:00:00 GMT
• taysha gene therapies inc (tsha) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 13:16:48 GMT
• taysha gene therapies inc (tsha) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 11:40:24 GMT
• taysha gene therapies inc (tsha) institutional confidence TradingKey Thu, 18 Jun 2026 11:08:21 GMT
• taysha gene therapies inc (tsha) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 05:24:57 GMT
• taysha gene therapies inc (tsha) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 22:49:40 GMT
• taysha gene therapies inc (tsha) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 22:49:21 GMT
• taysha gene therapies inc (tsha) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 21:57:11 GMT
• taysha gene therapies inc (tsha) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 21:56:10 GMT
• taysha gene therapies inc (tsha) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:49:38 GMT
• taysha gene therapies inc (tsha) institutional confidence TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• taysha gene therapies inc (tsha) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• taysha gene therapies inc (tsha) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• taysha gene therapies inc (tsha) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• taysha gene therapies (tsha) stock valuation after encouraging rett syndrome trial results and growing regulatory momentum simplywall.st Sun, 14 Jun 2026 13:23:56 GMT
• Taysha Gene Therapies (TSHA) Stock Looks Undervalued After Sharp Three Year Recovery Yahoo Finance Sat, 13 Jun 2026 07:00:00 GMT
• Taysha’s TSHA-102 Rett Data Links Clinical Promise To Future Revenue simplywall.st Sat, 13 Jun 2026 07:00:00 GMT
• Is Taysha Gene Therapies, Inc. (TSHA) A Good Stock To Buy Now? Yahoo Finance Thu, 11 Jun 2026 07:00:00 GMT
• earnings call transcript: taysha gene therapies q1 2026 misses eps and revenue targets Investing.com Nigeria Sat, 06 Jun 2026 04:59:37 GMT
• Four new Taysha hires get 714,700 RSUs and 468,600 options Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• Earnings call transcript: Taysha Gene Therapies Q1 2026 misses EPS and revenue targets Investing.com Nigeria Fri, 05 Jun 2026 07:00:00 GMT
• taysha gene therapies grants restricted stock units and stock options to new employees Quiver Quantitative Fri, 05 Jun 2026 07:00:00 GMT
• taysha gene therapies announces inducement grant under nasdaq listing rule 5635(c)(4) GlobeNewswire Fri, 05 Jun 2026 07:00:00 GMT
• taysha gene therapies shareholders back governance and leadership The Globe and Mail Wed, 03 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies (TSHA) director gets RSU and stock option grants Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Director Long Alison S Moomoo Tue, 02 Jun 2026 07:00:00 GMT
• taysha (tsha) director receives rsu and stock option awards, lifts holdings Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• taysha gene therapies (tsha) director receives rsu and stock option grants Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• equity awards for taysha (tsha) director alison s. long detailed Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• taysha gene therapies (nasdaq: tsha) holders approve board, auditor and annual say-on-pay Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• bmo capital maintains taysha gene therapies(tsha.us) with buy rating, maintains target price $10 富途牛牛 Mon, 01 Jun 2026 13:33:02 GMT
• taysha gene therapies inc annual shareholders meeting transcript GuruFocus Mon, 01 Jun 2026 13:00:00 GMT
• Taysha Gene Therapies: Shortened Timeline Increases The Potential (NASDAQ:TSHA) Seeking Alpha Mon, 01 Jun 2026 07:00:00 GMT
• Taysha Gene Therapies stock hits all-time high at 5.49 USD Investing.com Nigeria Sun, 24 May 2026 07:00:00 GMT
• b of a securities initiates coverage of taysha gene therapies (tsha) with buy recommendation MSN Sat, 23 May 2026 15:02:57 GMT
• taysha gene therapies stock hits all-time high at 5.49 usd Investing.com Sat, 23 May 2026 07:00:00 GMT
• ontario girl with rett syndrome denied access to promising gene therapy trial, parents say The Globe and Mail Sat, 23 May 2026 07:00:00 GMT
• bmo capital maintains taysha gene therapies(tsha.us) with buy rating, raises target price to $10 Moomoo Fri, 22 May 2026 07:00:00 GMT
• does taysha gene therapies' (tsha) rett breakthrough redefine its risk‑reward profile for investors? simplywall.st Thu, 21 May 2026 07:00:00 GMT
• taysha gene therapies (tsha) holds near support after modest gain - sell signal alerts newsline.com Thu, 21 May 2026 07:00:00 GMT
• taysha gene therapies’ swot analysis: stock faces pivotal trial test Investing.com Tue, 19 May 2026 07:00:00 GMT
• vestal point and ryan wilder hold 6.3% of taysha gene therapies (tsha) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• rtw investments and r. wong report 20.7m shares in taysha (nasdaq: tsha) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• possible bearish signals with taysha gene therapies insiders disposing stock Moomoo Thu, 14 May 2026 17:35:24 GMT
• tsha-102 construct design study advances rett syndrome research at asgct 2026 Traders Union Thu, 14 May 2026 15:22:35 GMT
• Taysha Gene Therapies (TSHA) Reports Financial Results for Q1 2026 Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
• what taysha gene therapies (tsha)'s wider q1 loss and tsha‑102 fda alignment means for shareholders simplywall.st Wed, 13 May 2026 13:29:46 GMT
• taysha gene therapies, inc. engages rettsyndrome community at patient first event Traders Union Tue, 12 May 2026 15:25:55 GMT
• Canaccord Keeps Buy Rating on Taysha (TSHA) After Q1 Highlights Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
Taysha Gene Therapies, Inc(NASDAQ:TSHA) 
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-101 for the treatment of GM2 gangliosidosis; TSHA-118 for the t...
Website: http://www.tayshagtx.com
Founded: 2019
CEO: R. A. Session
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends